10Y annualized return is
excellent
at 19.2% per year
BSX has met or exceeded earnings expectations in
most
recent quarters (9/10)
High Gross Profit Margin
Strong Operating Profit Margin
High PE Ratio
Elevated Price to Sales Ratio
Get access to all key takeaways, detailed financial metrics, and comprehensive stock analysis with our premium subscription.
Already have an account? Sign in
Overall, Boston Scientific demonstrates a strong business model with solid financial performance and competitive advantages, though it faces challenges from currency fluctuations and increasing competition. Its future prospects appear promising with guidance for continued growth and strategic acquisitions.
Analysis Date: February 5, 2025
Last Updated: May 29, 2025
Past performance does not guarantee future results. The data presented is indicative and may not be updated in real-time.
Boston Scientific Corporation makes medical devices that help doctors treat various health issues. They create products for surgeries and heart treatments, as well as devices for managing pain and cancer. Their tools help diagnose and fix problems in the digestive system, urinary system, and heart. Overall, Boston Scientific focuses on improving patient care through innovative medical technology.
Streams of revenue
Geographic Distribution
Core Products
Business Type
Business to Business
Competitive Advantages
Discover all competitive advantages and strategic moats that protect BSX's market position.
View Premium AnalysisKey Business Risks
Get comprehensive insight into all key business risks that could impact BSX's performance.
Access Full Risk AnalysisLatest News
In the latest trading session, Boston Scientific (BSX) closed at $95.12, marking a -0.14% move from the previous day.
Banking on robust above-market growth across all business units, BSX is expected to have witnessed strong international momentum in the first quarter.
Beyond analysts' top -and-bottom-line estimates for Boston Scientific (BSX), evaluate projections for some of its key metrics to gain a better insight...
Trailing Twelve Months (TTM) values provide a view of the company's performance over the last year.
Benjamin Graham's value investing approach focuses on finding stocks with a significant margin of safety between their intrinsic value and market price.
Access Benjamin Graham's value investing criteria, intrinsic value calculations, and margin of safety analysis
Trailing Twelve Months (TTM) values provide a view of the company's performance over the last year.
Profitability metrics measure a company's ability to generate earnings relative to its revenue, operating costs, and other relevant metrics. Higher values generally indicate better performance.
Access detailed profitability metrics with visual gauges and benchmarks
Access detailed analysis of profitability strengths and positive performance indicators
Upgrade to PremiumAccess detailed analysis of profitability weaknesses and areas of concern
Upgrade to PremiumFinancial health metrics assess a company's ability to meet its financial obligations and its overall financial stability.
Access detailed financial health metrics with visual gauges and risk assessments
Access detailed analysis of financial health strengths and stability indicators
Upgrade to PremiumAccess detailed analysis of financial health weaknesses and risk factors
Upgrade to PremiumMeeting Expectations
Higher values indicate better execution and credibility
Recent Results
View complete earnings history and detailed performance analysis
Upgrade to PremiumEPS
Revenue
Insider trading data shows purchase and sale activities by company executives and board members.
Insider trading patterns can provide insights into how company executives and board members view the stock's future prospects.
Get complete insider sentiment analysis with detailed trading patterns, sentiment indicators, and trend insights